Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Uniform Title
LEXIS (Information retrieval system)
Title
Royalty rates for pharmaceuticals and biotechnology.
Imprint
[Yardley, Pennsylvania] : IPRA, INC., 2012-
Distributed
[Place of distribution not identified] : [LexisNexis], [2015?]-
Description
1 online resource
Frequency
Updated regularly
Summary
Database is a tool that can be used to optimize the pricing of biotechnology and pharmaceutical intellectual property. The information in this resource is also useful for the valuation of patents and establishing damages for infringement litigation. The eighth edition of Royalty rates for pharmaceuticals & biotechnology continues to focus on the royalty rates associated with biotechnology and pharmaceutical intellectual property transfers. The database covers a wide variety of technologies. Just some of the technology categories represented in the database address: Alzheimer's, asthma, cardiovascular, cancer, contraception, diabetes, dermatology, drug delivery, hepatitis, and pain management, personal care, sleep therapy, and vaccines. This preface provides an overview of the data.
Note
Database includes most recent edition only.
Source of Description
Description based on source information screen, viewed Septernber 18, 2019.
Location
www
Linked Resources
Alternate Title
Lexis Advance Treatise
Call Number
LEXIS ADVANCE / LEXIS+
Language
English
Record Appears in